Xanpurin drug information: uses, indications, side effects, dosage. Compare prices for generic xanpurin substitutes: Xanol, Xanthomax, Xantozyl 300

Allopurinol belongs to a class of medications called xanthine oxidase inhibitors. It works by reducing the production of uric acid in the body. High levels of uric acid may cause gout attacks or kidney stones.

Jun 6, 2024 · Allopurinol is commonly used to treat gout, which is a form of arthritis caused by too much uric acid in your blood and joints. Allopurinol may also be used to lower your uric acid levels if...

The dosage of Xanpurin (Xanpurin) to accomplish full control of gout and to lower serum uric acid to normal or near-normal levels varies with the severity of the disease. The average is 200 to 300 mg/day for patients with mild gout and 400 to 600 mg/day for those with moderately severe tophaceous gout.

Allopurinol is used to treat gout and certain types of kidney stones. It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body.

The average is 200 to 300 mg/day for patients with mild gout and 400 to 600 mg/day for those with moderately severe tophaceous gout. The appropriate dosage may be administered in divided doses or as a single equivalent dose with the 300 mg-tablet.

Allopurinol is an inhibitor of xanthine oxidase, a substance in the body that is responsible for producing uric acid. It is used to treat gout and kidney problems due to high uric acid levels, as well as to prevent kidney stones for people with high uric acid levels.

<p> This medication is typically used for the prevention of goutto prevent kidney stones or to lower blood levels of uric acid. It may also have other uses. Even though you may not feel its effects, this medication takes effect after a few weeks. </p>

For the management of patients with signs and symptoms of primary and secondary gout (recurrent acute attacks, arthropathy, tophi, radiographic changes of gout, or associated uric acid nephrolithiasis); For the management of patients with leukemia, lymphoma and solid tumor malignancies who are undergoing chemotherapy expected to result in tumor ...

Treatment of gout either primary or secondary to the hyperuricemia associated with blood dyscrasias and their therapy, primary or secondary uric acid nephropathy, with or without accompanying symptoms of gout; recurrent uric acid formation.